Skip to main content

Site notifications

We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

Pharmacor Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (674)
Cancellation by sponsor (99)
Prescription medicine registration (44)
Cancellation or suspension (21)
Australian public assessment report (AusPar) (1)

Date

2026 (32)
2025 (74)
2024 (49)
2023 (53)
2022 (131)
2021 (82)
2020 (79)
2019 (56)
2018 (91)
2017 (41)
2016 (22)
2015 (13)
2014 (55)
2013 (21)
2012 (9)
2011 (7)
2010 (18)
2009 (3)
2007 (2)
1991 (1)

Search

Sponsor content

839 result(s) found, displaying 691 to 700

PHARMACOR DULOXETINE duloxetine hydrochloride 60 mg enteric capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
PHARMACOR DULOXETINE duloxetine hydrochloride 30 mg enteric capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
PHARMACOR TACROLIMUS tacrolimus 1 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
PHARMACOR TACROLIMUS tacrolimus 5 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
PHARMACOR TACROLIMUS tacrolimus 0.5 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
PHARMACOR METFORMIN 500 metformin hydrochloride 500mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
TRUST Day/Night Cold and Flu Relief Tablets Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
PHARMACOR CITALO 20 citalopram hydrobromide 20 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
FINASTERIDE-GA 5 finasteride 5 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
AKM-TICAGRELOR (Pharmacor Pty Ltd)

31 May 2018

Prescription medicine registration

Active ingredients: Ticagrelor.

Pages

First page
Previous page
…
Page 66
Page 67
Page 68
Page 69
Current page 70
Page 71
Page 72
Page 73
Page 74
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia